Bovine TB infection status in cattle in Great Britain in 2015.

This report, provided by the APHA, presents the key descriptive epidemiological parameters of bovine TB in cattle in Great Britain from January 1 to December 31, 2015, providing summary information on the epidemic, including key statistics and epidemiological parameters as presented in the annual surveillance report for Great Britain, with supporting detail from specific reports for England and Wales. It updates the previous annual summaries for 2012 to 2014, also published in Veterinary Record.

Bovine TB surveillance in Great Britain in 2014.

This report, provided by the APHA, summarises the key descriptive epidemiological parameters of bovine TB in cattle in Great Britain from January 1 to December 31, 2014. It summarises some of the temporal trends observed over a longer period and highlights some differences and similarities between Scotland, Wales and the three bovine TB risk areas of England. It updates the previous annual summaries for 2012 and 2013, also published inVeterinary Record(VR, June 14, 2014, vol 174, pp 600-604; March 28, 2015, vol 176, pp 326-330).

Responses to diagnostic tests for bovine tuberculosis in dairy and non-dairy cattle naturally exposed to Mycobacterium bovis in Great Britain.

Field surveillance of British cattle using the single intradermal comparative cervical tuberculin (SICCT) test shows a higher incidence rate of bovine tuberculosis (bTB) in dairy compared to beef herds, but a lower probability of post-mortem examination confirmed (PMC) Mycobacterium bovis infection in dairy herds. A cross-sectional study was conducted to compare animal level differences in bTB detection between dairy and non-dairy cattle in Great Britain. During the period from 2002 to 2005, 200 (41% dairy) reactors in the SICCT test (standard interpretation) were randomly selected, and 200 in-contact cattle (43% dairy) were purposively selected from bTB-infected herds. Interferon (IFN)-γ responses in blood to bovine and avian purified protein derivative (PPD), and early secretory antigen target 6 kDa and culture filtrate protein 10 (ESAT-6/CFP10), were measured. The post-mortem examination included gross pathological examination, mycobacterial culture and histopathology. The proportions of cattle positive to ESAT6/CFP10 were 26% (95% confidence interval, CI, 15-39%) in dairy reactors and 62% (95% CI 51-72%) in non-dairy reactors (P <0.001). PMC risk was 34% (95% CI 24-45%) in dairy reactors and 69% (95% CI 60-78%) in non-dairy reactors (P <0.001). The odds ratio for PMC risk in dairy reactors compared to non-dairy reactors, after controlling for bTB prevalence, herd size and SICCT test response, was 0.27 (95% CI 0.14-0.53; P <0.001). In surveillance data, adjusted animal level PMC risks were lower for dairy reactors than for beef reactors aged >2 years (P <0.001).

Bovine TB infection status in cattle in Great Britain in 2013.

This report, provided by the APHA, summarises the infection status of bovine TB in cattle in Great Britain from January 1 to December 31, 2013 and describes some of the temporal trends observed over a longer period. It updates the previous annual summary for 2012, also published in Veterinary Record (VR, June 14, 2014, vol 174, pp 600-604).

Bovine TB infection status in cattle in Great Britain in 2012.

This report, provided by the AHVLA, summarises the infection status of bovine tuberculosis (TB) in cattle in Great Britain from January 1 to December 31, 2012 and describes some of the temporal trends observed over a longer period. The AHVLA intends to produce similar reports for future years to provide a concise summary of how the situation is developing.

Mycobacterium bovis infections in domesticated non-bovine mammalian species. Part 1: Review of epidemiology and laboratory submissions in Great Britain 2004-2010.

Mycobacterium bovis, the causative agent of bovine tuberculosis (bTB), can infect a broad range of mammalian species in addition to domestic and feral cattle and badgers. Since legislation introduced in 2006 in Great Britain requires animal keepers, meat inspectors and veterinarians to notify the authorities of suspect bTB lesions or the isolation of M. bovis in any mammal excluding humans, the organism has been increasingly identified in domestic species other than cattle. Although in most cases 'spill-over' hosts, these remain a potential source of infection for cattle, wildlife, and possibly humans. In this first part of a two-part review of M. bovis infections in non-bovine domestic species, current knowledge of the epidemiology of such infections is presented along with novel data relating to diagnostic submissions for mycobacterial culture between 2004 and 2010. Over this period M. bovis infection was identified in 116 cats, 7 dogs, 34 llamas, 133 alpacas, 35 goats, 24 sheep and 85 pigs and wild boar. The risk that such infections pose to the control of bTB, and as zoonoses, is discussed. In part two, the options available to diagnose bTB in these species, as well as the challenges posed to disease detection and control will be discussed in depth.

Tuberculin manufacturing source and breakdown incidence rate of bovine tuberculosis in British cattle, 2005-2009.

The single intradermal comparative cervical tuberculin (SICCT) test is the primary test used for surveillance for bovine tuberculosis (bTB) in cattle in Great Britain (GB). The tuberculin used can, with other factors, influence test accuracy. In this analysis, the detection of infected cattle in GB 2005-2009 was compared between SICCT tests using tuberculins manufacturered by different manufacturers. Higher rates of reactors (adjusted rate 209 vs 186 per 100,000 tests, P = 0.003) and herd bTB incidents (adjusted total breakdown rate 5.1 vs 4.5 per 100 herd-years at risk, P < 0.001) were detected using tuberculin manufactured at Weybridge compared with Lelystad. However, confirmation of infection in reactors by postmortem evidence was higher with Lelystad tuberculin (adjusted percent 44.1 vs 47.1, P = 0.018). The findings, overall, suggest slightly higher test sensitivity and lower test specificity associated with Weybridge tuberculin compared with Lelystad. Assuming effective adjustment for confounding, the overall impact of tuberculin manufacturing source (2007-2009), was calculated to range somewhere between 315 false positive breakdowns, and 1086 bTB breakdowns missed (624 confirmed) as a result of using Weybridge and Lelystad tuberculin, respectively. However, animals that tested negative to the SICCT were not slaughtered at the time of the tests, so definitive conclusions are not possible.

Inadequate pre-season preparation of schoolboy rugby players--a survey of players at 25 Cape Province high schools.

OBJECTIVE: To establish the previous rugby experience, the knowledge and the use of injury prevention techniques by South African schoolboy rugby players. DESIGN: Before the first full-contact match of the 1991 rugby season, 2,330 players completed a detailed questionnaire. SETTING: High schools in the Cape Province. Three thousand three hundred and thirty players from 25 schools selected because of a record of excellence in and commitment to schoolboy rugby. MAIN OUTCOME MEASURES: Personal data including age, height, mass and rugby experience; history and nature of previous rugby injuries; knowledge of techniques known to prevent rugby injuries; parental and personal reasons for playing rugby. RESULTS: The incidence and distribution of the different types of injuries previously sustained by the players were the same as those identified prospectively in the same population. A-team players were significantly heavier and taller than players in lower teams in most playing positions in most age groups. Although A-team players were more likely to participate in pre-season endurance or strength training, fewer than 40% of players overall trained adequately in the pre-season. Less than 30 minutes was allocated to the practice of tackling and falling techniques prior to the first full-contact match. Knowledge of different high-risk situations during play was generally sketchy, and only 24% of players wore gumguards all the time. More fathers (84%) than mothers (63%) encouraged their sons to play rugby. CONCLUSIONS: The results indicate that the incidence and nature of the injuries reported retrospectively were similar to those reported in prospective studies at the same schools. The players' knowledge of techniques known to prevent rugby injuries was inadequate and too little attention was paid at the start of the rugby season to training and coaching techniques to reduce injury risk. Coaching errors may therefore have predisposed players to injury.

Thermal pants may reduce the risk of recurrent hamstring injuries in rugby players.

OBJECTIVE: To determine whether the use of thermal pants might reduce the risk of hamstring injury in rugby players. METHODS: 44 male rugby players from the Cape Province, South Africa, who had previously suffered a hamstring injury were given the choice of wearing thermal warming pants or not, and were then monitored for the development of hamstring injuries during the 1992 season. RESULTS: In the group who wore warmers some of the time, the injury rate was significantly lower when using the warmers (3 injuries/1000 playing hours) than when not (57/1000 playing hours). There was no difference in injury rates between groups who either wore warmers all the time or none of the time, probably because the number who wore the warmers all the time was small (n = 5). Eighteen percent of the injuries recurred at exactly the same site in the muscle and within 12 d of returning to rugby after the initial injury. The incidence of injury was high in the first three weeks of the season and again in the same period after the mid-season break. More than 80% of all match and practice time lost by these players during the study was a direct result of their hamstring injuries. CONCLUSIONS: Thermal pants may have a role in preventing recurrent hamstring injuries but other factors such as inadequate preseason training and incomplete rehabilitation after injury are likely to be more significant risk factors for injury.

Escherichia coli O157:H7; an economic assessment of an outbreak.

BACKGROUND: The aim of the study was to assess the impact of an outbreak of Escherichia coli O157:H7 that occurred in 1994 in a rural community, with a population of approximately 107,000, to the west of Edinburgh. METHODS: The impact of the outbreak was assessed during the acute phase of the illness and in the subsequent 12 months. The method involved three surveys of confirmed cases using general practice notes, hospital records and interviews with cases. Key persons involved in the investigation and control of the outbreak were also interviewed. The impact of the illness on cases and their families was estimated and the resources used to treat cases and to control the outbreak were costed and long-term costs projected. RESULTS: There were 71 cases whose ages ranged from 7 months to 84 years. The mortality rate was 1.4 per hundred cases. There were 10 cases of haemolytic uraemic syndrome (HUS) and one case of thrombotic thrombocytopenia purpura (TTP). Two children were on long-term dialysis. Co-morbidity involving the immune system was associated with hospital admission. The illness lasted on average 6.9 weeks. Twenty-six per cent of cases reported symptoms 12 months later. The average cost per HUS case was 62,353 pound sterlings, the TTP case cost 21,422 pound sterlings, non-HUS and non-TTP cases cost 1,030 pound sterlings. The costs of investigating and controlling the outbreak were 171,848 pound sterlings. The costs of cases projected over 30 years were 11.9 million pound sterlings, or 168,032 pound sterlings per case. CONCLUSIONS: The impact on the health of cases was considerable and the costs were high. Every effort should be made to prevent the disease and to identify and control outbreaks quickly.

Acute hepatitis B in Edinburgh 1975-92: a retrospective study in a population where human immunodeficiency virus is highly prevalent.

A retrospective study of notified hepatitis B virus (HBV) infection in Edinburgh during 1975-92 identified 525 acute cases. For 343 where a probable transmission route could be determined, 215 were due to shared equipment by injection drug users (IDUs), 29 to homosexual intercourse, 25 to heterosexual or household contact with IDUs, 21 to heterosexual contact with infected non-IDU partners and 53 to various other or multiple routes. Cases were unevenly distributed geographically, particularly those among IDUs. The highest incidence within a post code district was approximately 2.5 times that for all Edinburgh. Annual cases peaked in 1984 then declined to low levels in the early 1990s. This reduction was most marked among IDUs, and may be ascribed both to changed injecting behaviour and decreased susceptibility within this group. The latter factor implies that HBV infections may be an unreliable guide to human immunodeficiency virus (HIV) infection in populations where HBV is highly prevalent.